Federal Register, Volume 61 Issue 216 (Wednesday, November 6, 1996)

[Federal Register Volume 61, Number 216 (Wednesday, November 6, 1996)]
[Notices]
[Pages 57436-57438]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-28502]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[INFO-97-28]

Proposed Data Collections Submitted for Public Comment and
Recommendations

In compliance with the requirement of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for opportunity for public comment on
proposed data collection projects, the Centers for Disease Control and
Prevention (CDC) will publish periodic summaries of proposed projects.
To request more information on the proposed projects or to obtain a
copy of the data collection plans and instruments, call the CDC Reports
Clearance Officer on (404) 639-7090.
Comments are invited on: (a) Whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; and (d) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques for other
forms of information technology. Send comments to Wilma Johnson, CDC
Reports Clearance Officer, 1600 Clifton Road, MS-D24, Atlanta, GA
30333. Written comments should be received within 60 days of this
notice.

Proposed Projects

1. The National Home and Hospice Care Survey (NHHCS)--(0920-0298)--
Revision--The National Home and Hospice Care Survey (NHHCS) was
conducted in 1992, 1993, 1994 and 1996. It is part of the Long-Term
Care component of the National Health Care Survey. Section 306 of the
Public Health Service Act states that the National Center for Health
Statistics ``shall collect statistics on health resources * * * [and]
utilization of health care, including utilization of * * * services of
hospitals, extended care facilities, home health agencies, and other
institutions.'' NHHCS data are used to examine this most rapidly
expanding

[[Page 57437]]

sector of the health care industry. Data from the NHHCS are widely used
by the health care industry and policy makers for such diverse analyses
as the need for various medical supplies; minority access to health
care; and planning for the health care needs of the elderly. The NHHCS
also reveals detailed information on utilization patterns, as needed to
make accurate assessments of the need for and costs associated with
such care. Data from earlier NHHCS collections have been used by the
Congressional Budget Office, the Bureau of Health Professions, the
Maryland Health Resources Planning Commission, the National Association
for Home Care, and by several newspapers and journals. Additional uses
are expected to be similar to the uses of the National Nursing Home
Survey. NHHCS data cover: baseline data on the characteristics of
hospices and home health agencies in relation to their patients and
staff, Medicare and Medicaid certification, costs to patients, sources
of payment, patients' functional status and diagnoses. Data collection
is planned for the period July-October, 1997. Survey design is in
process now. Sample selection and preparation of layout forms will
precede the data collection by several months. The total cost to
respondents is estimated at $172,500.

----------------------------------------------------------------------------------------------------------------
No. of Avg. burden/ Total
Respondents No. of responses/ response burden (in
respondents respondent (in hrs.) hrs.)
----------------------------------------------------------------------------------------------------------------
Agency Questionnaire....................................... 1,200 1 0.333 400
Current Patient Sampling List.............................. 1,200 1 0.333 400
Current Patient Questionnaire.............................. 1,200 6 0.25 1,800
Discharged Patient Sampling List........................... 1,200 1 0.50 600
Discharged Patient Questionnaire........................... 1,200 6 0.25 1,800
----------------------------------------------------
Total................................................ 5,000
----------------------------------------------------------------------------------------------------------------

2. Childhood Lead Poisoning Prevention Program Quarterly Report
(0902-0282)--Extension--Lead poisoning is the most common and
societally devastating environmental disease of young children in the
United States. Severe lead exposure can cause coma, convulsions, and
even death. Lower levels of lead, which rarely cause symptoms, can
result in decreased intelligence, developmental disabilities, and
behavioral disturbances. State and community health agencies are the
principal delivery points for childhood lead screening and related
medical and environmental management activities. In FY 1996, CDC
awarded 40 grants to fund childhood lead poisoning prevention programs.
The primary purpose of these grants is for the initiation or expansion
of state- and community-based childhood lead poisoning prevention
programs that do the following: (1) screen infants and children for
elevated blood lead levels, (2) assure referral for treatment of, and
environmental intervention for, infants and children with elevated
blood lead levels, and (3) to provide education about childhood lead
poisoning. The purpose of the quarterly report is to report data
collected by CDC's grantees. The report consists of narrative and data
sections. The purpose of the narrative section is to provide the
following: (1) highlights of quarterly activities, (2) discuss issues
and activities that have significant impact on the program, (3) list
objectives and discuss progress towards meeting those objectives. The
purpose of the data section is to provide the following: (1) screening
and case confirmation activities, (2) environmental inspection and
hazard remediation activities, and (3) medical case management
activities. The total cost to the respondents is $0.00.

3. Validation of Self-Reported Health Outcomes from the Health
Assessment of Persian Gulf War Veterans From Iowa--Extension with
change--The purpose of this proposed study is to collect additional
data to validate health outcomes reported by participants in the Health
Assessment of Persian Gulf War Veterans From Iowa. The original data
collection consisted of a telephone survey of 3,695 military personnel
who served during the time of the Persian Gulf War and listed Iowa as
their home of residence. Data will be collected from subjects who
participated in the telephone survey to validate the self-report of
four health outcomes: cognitive dysfunction, depression, asthma, and
multi systemic conditions. Neuropsychological testing will be
administered to validate cognitive dysfunction. Structured clinical
interviews for mental disorders and paper-and-pencil questionnaires
will be administered to validate depression. Lung function assessment,
tests of airways hyperactivity, and standard respiratory health
questionnaires will be administered to validate asthma. Review of
medical records, standard physical examination, and laboratory
evaluation will be conducted to validate multi systemic conditions,
including chronic fatigue syndrome and fibromyalgia. In addition, a
feasibility study will be conducted to explore the usefulness of two
databases established by the Department of Defense, the Troop Exposure
Assessment Model and the Registry of Unit Locations, to validate self-
reported exposures among Persian Gulf War veterans who participated in
the Iowa telephone survey. The total cost to the respondents is $0.00.

[[Page 57438]]

----------------------------------------------------------------------------------------------------------------
No. of Avg. burden/
Respondents No. of responses/ response (in Total burden
respondents respondent hrs.) (in hrs.)
----------------------------------------------------------------------------------------------------------------
Case Validation of Cognitive Dysfunction

----------------------------------------------------------------------------------------------------------------
PGW Exposed Veterans with self- reported symptoms of
Cognitive Dysfunction. Full neuropsychological exam...... 100 1 4.0 400
Non-PGW Veterans with self-reported symptoms of Cognitive
Dysfunction. Full neuropsychological exam................ 100 1 4.0 400
Normal Controls (PGW/Non-PGW Veterans denying symptoms of
Cognitive Dysfunction). Cognitive testing................ 100 1 2.0 200
-----------------------------------------------------
Total..................................................... ........... ........... ............ 1000

----------------------------------------------------------------------------------------------------------------
Case Validation for Asthma

----------------------------------------------------------------------------------------------------------------
PGW Exposed and Non-PGW Veterans self-reporting asthma.
Questionnaire (ATS and Adult Respiratory Health);
Pulmonary Function Tests (spirometry, DLCO, lung
volumes); Histamine Challenge............................ 50 1 2.25 112.5
Normal Controls. (PGW/Non-PGW Vets denying symptoms of
asthma). Questionnaire (ATS and Adult Respiratory
Health); Pulmonary Function Tests (spirometry, DLCO, lung
volumes); Histamine Challenge............................ 50 1 2.25 112.5
-----------------------------------------------------
Total............................................... ........... ........... ............ 225

----------------------------------------------------------------------------------------------------------------
Case Validation of Depression

----------------------------------------------------------------------------------------------------------------
PGW Exposed Veterans reporting ``any type of depression.''
Questionnaire (Structured Clinical Interview and Family
History-Research Diagnostic Criteria).................... 50 1 3.0 150
Non-PGW Exposed Veterans reporting ``any type of
depression.'' Questionnaire (Structured Clinical
Interview and Family History-Research Diagnostic
Criteria)................................................ 50 1 3.0 150
-----------------------------------------------------
Total............................................... ........... ........... ............ 300

----------------------------------------------------------------------------------------------------------------
Validation of Multi-Systemic Illnesses

----------------------------------------------------------------------------------------------------------------
PGW Exposed and Non-PGW Veterans reporting symptoms of
chronic fatigue, fibromyalgia, and/or multiple chemical
sensitivity. Iowa Persian Gulf Study Questionnaire;
Physical exam............................................ 243 1 3.0 729
Normal Control (PGW/Non-PGW Veterans denying symptoms of
chronic fatigue, fibromyalgia, and/or multiple chemical
sensitivity). Iowa Persian Gulf Study Questionnaire;
Physical exam............................................ 116 1 3.0 348
-----------------------------------------------------
Total............................................... ........... ........... ............ 1077
----------------------------------------------------------------------------------------------------------------

Wilma G. Johnson,
Acting Associate Director for Policy Planning and Evaluation, Centers
for Disease Control and Prevention (CDC).
[FR Doc. 96-28502 Filed 11-5-96; 8:45 am]
BILLING CODE 4163-10-P